Devyser Diagnostics AB has been awarded a tender for Devyser?s CFTR fragment analysis products, that are used for screening and confirmation of cystic fibrosis. The tender with the University Hospital in Verona is valid for a period of twelve months. Indicative order value is estimated to amount to approximately SEK 1.5 million .